The relationship between transfusion dependency and health-related quality of life in patients with myelodysplastic syndromes may differ based on disease risk at diagnosis.
Insurance status heavily influenced treatment and survival outcomes among patients with Burkitt lymphoma, but not patients with plasmablastic lymphoma.
Second malignant neoplasms have increased among younger patients with multiple myeloma.
More than one-fifth of patients undergoing hematopoietic cell transplantation reported a lack of awareness of financial burden prior to the procedure.
Overall costs of radiation therapy for early-stage breast cancer do not burden the health care system when analyzed in relation to survival benefit.
Weight loss was associated with a reduced risk for breast cancer among postmenopausal women.
Nearly one in five women with early-stage breast cancer received guideline-discordant treatment, usually with regards to chemotherapy use.
The dose-rounding of certain monoclonal antibodies plus or minus 10% produced significant cost and waste savings.
A panel presented at ASHP highlighted the anticipated advancements expected in payment models in 2018, alongside the use of analytics and claims data for optimal health care payment strategies.
Guideline-based management approaches can improve quality of care and outcomes for patients with heart failure and arrhythmic complications.